Infectious Diseases Research Program, Providence Veterans Affairs Medical Center, Providence, RI, USA.
Center of Innovation in Long-Term Support Services, Providence Veterans Affairs Medical Center, Providence, RI, USA.
J Med Microbiol. 2022 Oct;71(10). doi: 10.1099/jmm.0.001594.
. is an important multidrug-resistant Gram-negative pathogen. While largely a hospital-acquired pathogen, there have been increasing reports of the pathogen in the community.. Trends in prevalence and resistance rates that include outpatient isolates are unknown.. We described recent trends in prevalence and resistance of in the national Veterans Affairs (VA) Healthcare system.. The study identified positive clinical cultures among VA adult patients from 2010 to 2018 across all VA hospitals, long-term care facilities/units, and outpatient settings. Annual resistance rates were evaluated. Multidrug resistant (MDR) was defined as resistance to sulfamethoxazole/trimethoprim (SMX/TMP) and minocycline or levofloxacin. Time trends were assessed with regression analyses to estimate annual average percent changes (AAPC) with 95 % confidence intervals using Joinpoint software.. Over the 9 year study period, 18 285 . cultures were identified (57 % hospital, 3 % long-term care, 40 % outpatient). The most common source of cultures were respiratory cultures (34.6 %) followed by urine cultures (30.4 %). In VA hospitals and long-term care facilities, the number of cultures decreased significantly (by 5.4% and 8.4 % per year respectively). Overall, 3.1 % of isolates were MDR which remained stable over the study period. Resistance to other antibiotics assessed mostly remained stable, except SMX/TMP resistance decreased significantly by 8.5 % (2010, 15 %; 2018, 6 %) per year in VA hospitals.. While previous work has recognized as primarily a nosocomial pathogen, the present study found that 40 % of cultures collected were among outpatients. Between 2010 and 2018, the number of positive cultures decreased significantly in the national VA Healthcare System. Resistance to SMX/TMP decreased over the study period in VA hospitals and now more closely reflects previously reported resistance rates worldwide (0-10 %). MDR remained stable and low in the national VA Healthcare System.
. 是一种重要的多重耐药革兰氏阴性病原体。虽然它主要是医院获得性病原体,但越来越多的社区病原体报告。. 包括门诊分离株在内的 流行趋势和耐药率尚不清楚。. 我们描述了全国退伍军人事务部(VA)医疗保健系统中 流行趋势和耐药性的最新趋势。. 该研究确定了 2010 年至 2018 年间 VA 所有医院、长期护理设施/单位和门诊环境中成年患者的阳性 临床培养物。评估了每年的耐药率。多药耐药(MDR)定义为对磺胺甲恶唑/甲氧苄啶(SMX/TMP)和米诺环素或左氧氟沙星的耐药性。使用 Joinpoint 软件评估时间趋势,以回归分析估计每年平均百分比变化(AAPC)及其 95%置信区间。. 在 9 年的研究期间,鉴定了 18285 株 。培养物(57%医院,3%长期护理,40%门诊)。 培养物最常见的来源是呼吸道培养物(34.6%),其次是尿液培养物(30.4%)。在 VA 医院和长期护理设施中, 的数量显著减少(每年分别减少 5.4%和 8.4%)。总的来说,3.1%的分离株为 MDR,在研究期间保持稳定。评估的其他抗生素的耐药性大多保持稳定,除了磺胺甲恶唑/甲氧苄啶的耐药性每年显著下降 8.5%(2010 年为 15%;2018 年为 6%)在 VA 医院。. 虽然之前的研究已经认识到 主要是一种医院病原体,但本研究发现,40%的培养物是在门诊病人中收集的。2010 年至 2018 年间,全国退伍军人事务部医疗保健系统中阳性 的数量显著减少。磺胺甲恶唑/甲氧苄啶的耐药性在 VA 医院研究期间有所下降,现在更接近全球报告的耐药率(0-10%)。MDR 在全国退伍军人事务部医疗保健系统中保持稳定且较低。